Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Value in Health Special Issue: Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the U.S. and Other Countries

This special issue of Value in Health showcases presentations made at the Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the U.S. and Other Countries symposium held on May 15, 2009.

Articles in this issue include the following:

  • Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the US and Other Countries (pages S1–S3), Adrian R. Levy and Louis P. Garrison Jr.
  • Health Technology Assessment in the United Kingdom (pages S4–S5), Ron Akehurst
  • Health Technology Assessment and Comparative Effectiveness in Sweden (pages S6–S7), Egon Jonsson
  • Conditionally Funded Field Evaluations: PATHs Coverage with Evidence Development Program for Ontario (pages S8–S11), Ron Goeree, Kiran Chandra, Jean-Eric Tarride, Daria O'Reilly, Feng Xie, James Bowen, Gord Blackhouse and Robert Hopkins
  • Comparative Assessment for Medications and Devices: Apples and Oranges? (pages S12–S14), Scott Ramsey
  • Contemporary Challenges in Deriving Summary Estimates of Comparative Effectiveness Using Meta-Analysis (pages S15–S17), Edward J. Mills
  • Reflecting Heterogeneity in Patient Benefits: The Role of Subgroup Analysis with Comparative Effectiveness (pages S18–S21), Mark Sculpher
  • Transportability of Comparative Effectiveness and Cost-Effectiveness between Countries (pages S22–S25), Andrew Briggs
  • Experimental and Observational Data and Formulary Listing (pages S26–S29), Raulo S. Frear
  • Net Clinical Benefit: The Art and Science of Jointly Estimating Benefits and Risks of Medical Treatment (pages S30–S32), Adrian Towse

Due to copyright issues, articles must be accessed through the Value in Health website. NPC has limited print copies available for order.

Blog Post

#TBT: Expanding Your Horizons: CER Continuing Education Certificate Program

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

CER Tweets of the Week: Improving Patient Care Remains Hot Topic (July 14 - 18)

Evidence-based medicine (EBM) and the role of big data in improving patient care continued to be hot topics among comparative effectiveness research...
Blog Post

CER Tweets of the Week: Patient-Generated Data, Value-Based Payment Programs & Impact of CER (July 7 - 11)

Which issues attracted comparative effectiveness research (CER) stakeholders’ attention this week in the Twitterverse? ...
Blog Post

#TBT: Consumer-Directed Health Plans & Employers’ Decision-Making

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Press Release

NPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon

(Washington, DC, May 19, 2014)—A new survey of health care stakeholders reveals continued optimism for the use of comparative effectiveness research...
Press Release

CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools

(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important guidance to aid formulary decision-makers...
Press Release

NPC, Quintiles Study Tests Tools to Evaluate Quality of Observational Research in Comparative Effectiveness Studies

(Washington, DC, February 25, 2014)—With the growing demand for information about comparative effectiveness and questions about the quality of...
Press Release

NPC, UMD Study: Factors That Cause Different Treatment Responses Are Not Well Understood or Studied

Washington, DC, November 4, 2013—Although researchers and health care providers widely recognize that individuals with stage IV prostate cancer react...
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
YouTube Videos

Incorporating Patient Views Into Health Technology Assessments

David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health technology assessments are incorporating...
YouTube Videos

Health Technology Assessments and Specialty Medications

David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often challenges in conducting health technology...
YouTube Videos

Differences in Global Health Technology Assessment

David Grainger, senior director, global public policy, Eli Lilly and Company, describes how health technology assessment (HTA) informs policy and...
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study suggesting that changes are needed...
Blog Post

#TBT: Expanding Your Horizons: CER Continuing Education Certificate Program

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

CER Tweets of the Week: Improving Patient Care Remains Hot Topic (July 14 - 18)

Evidence-based medicine (EBM) and the role of big data in improving patient care continued to be hot topics among comparative effectiveness research...
Blog Post

CER Tweets of the Week: Patient-Generated Data, Value-Based Payment Programs & Impact of CER (July 7 - 11)

Which issues attracted comparative effectiveness research (CER) stakeholders’ attention this week in the Twitterverse? ...
Blog Post

#TBT: Consumer-Directed Health Plans & Employers’ Decision-Making

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...

Research

  •  
  • 1 of 12
  • >

Commentary & Testimony